Compounds > sofosbuvir
Page last updated: 2024-08-25

sofosbuvir and Melanoma

sofosbuvir has been researched along with Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Beeharry, N; Bellacosa, A; Bhattacharjee, V; Cosentino, L; Davidson, G; Davidson, I; Devarajan, K; Dorjsuren, DG; Einarson, M; Giordano, A; Jelinek, J; Kadariya, Y; Katz, RA; Larue, L; Mancuso, P; Nicolas, E; Simeonov, A; Sobol, RW; Sun, H; Testa, JR; Tricarico, R; Yen, TJ1
Berg, C; Eigentler, T; Forschner, A; Geipel, A; Kofler, K; Kofler, L; Lipp, HP; Müller, A1
Khattak, MA; Kothapalli, A1
Chin, B; Khattak, MA; Menon, LL1

Other Studies

4 other study(ies) available for sofosbuvir and Melanoma

ArticleYear
Thymine DNA glycosylase as a novel target for melanoma.
    Oncogene, 2019, Volume: 38, Issue:19

    Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytosine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Melanoma, Experimental; Mice, Knockout; Mice, SCID; Mice, Transgenic; Molecular Targeted Therapy; Thymine DNA Glycosylase; Xenograft Model Antitumor Assays

2019
Simultaneous targeted therapy for metastatic melanoma and hepatitis C.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020, Volume: 18, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Benzimidazoles; Fluorenes; Hepatitis C, Chronic; Humans; Imidazoles; Melanoma; Oximes; Pyridones; Pyrimidinones; Skin Neoplasms; Sofosbuvir; Uridine Monophosphate

2020
Safety and efficacy of anti-PD-1 therapy for metastatic melanoma and non-small-cell lung cancer in patients with viral hepatitis: a case series.
    Melanoma research, 2018, Volume: 28, Issue:2

    Topics: Aged; Antibodies, Monoclonal, Humanized; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Fluorenes; Hepatitis B; Hepatitis C; Humans; Interferons; Lung Neoplasms; Male; Melanoma; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Skin Neoplasms; Sofosbuvir

2018
Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir).
    Internal medicine journal, 2018, Volume: 48, Issue:12

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antiviral Agents; Benzimidazoles; Clinical Decision-Making; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Sofosbuvir; Treatment Outcome; Uridine Monophosphate

2018